fluorotyrosinamides (N-Ac-F n Y-NH 2 s) have been characterized in solution and found to have phenolic pK a s from 5.6-8. 4 and peak potentials ranging from 705-968 mV. 3, 4 This series of Y analogs provides a means of systematically modulating the chemical properties governing both the PT and ET events.
Ribonucleotide reductase (RNR) catalyzes the formation of all four 2′-deoxynucleotides from the corresponding nucleoside diphosphates (NDPs) by a mechanism involving protein and nucleotide radicals. 1 In the class Ia RNRs, a stable difer-ric-Y• cofactor in the β2 subunit initiates catalysis by transiently oxidizing a cysteine at the active site in the α2 subunit. The mechanism of radical initiation has been best studied in the E. coli RNR, and is believed to involve an unprecedented mechanism of reversible long-range (>35 Å) PCET along a pathway of absolutely conserved redox active amino acids: Y 122 • ↔ [W 48 ?] ↔ Y 356 in β2 to Y 731 ↔ Y 730 ↔ C 439 in α2 (Scheme 1). 5, 6 This hypothesis has been tested by the site-specific incorporation of more than a half-dozen unnatural amino acids (UAAs) into positions along the pathway, using both expressed protein ligation (EPL) 7 and in vivo nonsense suppression 8, 9 techniques. Studies in which a series of F n Ys were incorporated at position 356 of β2 by EPL were particularly informative, as pH rate profiles of the resulting proteins indicated that this residue was redox active, that proton and electron movement is orthogonal at this position (Scheme 1) and that an ordered hydrogen bonding network involving the Y 356 phenol is not necessary for catalysis. 10, 11 F n Ys incorporated in place of other conserved Ys along the pathway would be comparably informative. However, the EPL technology used to generate Y 356 F n Y-β2s can not be readily extended to positions in the protein interior. While other strategies for incorporation of F n Ys exist, namely global incorporation 4, 12 or site-specific insertion of photocaged F n Ys, 13 these techniques are applicable to mono-and di-F n Ys only and are minimally useful in RNR, as the former lacks specificity and the latter has complications arising from photolysis. 14 Herein, a robust method for the in vivo site-specific incorporation of a series of F n Ys is reported. This method requires evolution of an orthogonal aaRS-tRNA pair and has been successfully used to incorporate over 70 UAAs into E. coli, S. cervevisiae, and mammalian proteins in response to a nonsense (or "blank") codon. 15, 16 Originally, we sought to evolve an aaRS specific for 2,3,5-trifluorotyrosine (2,3,5-F 3 Y, 1), as previous data suggested that its redox potential is sufficiently increased relative to Y at appropriate pHs such that its incorporation at position 356 of β2 changes the rate-determining step in RNR from a conformational change 17 to PCET. 11 Three fluorine substituents together with the low phenolic pK a (6.4) were expected to allow evolution of an RS selective for the phenolate of 1 over the Y phenol.
To selectively incorporate 1 into proteins, an orthogonal Methanococcus jannaschii aaRStRNA pair that suppresses the amber stop codon (TAG) was evolved to uniquely encode this amino acid by a double sieve selection process based on cellular viability. 16 A library of TyrRS mutants was generated by randomizing eight positions near the active site, based on the known structure of Tyr-bound MjTyrRS, 18 including those residues closest to the aromatic ring (Y32, L65, and H70) and those involved in H-bonding to the Y phenol (Y32 and D158). The library was subjected to three positive and negative selection cycles, after which individual candidates were isolated and assessed for viability in the presence and absence of 1 at different chloramphenicol (Cm) concentrations. The selection resulted in two primary clones, E3 (Y32L, L65G, H70N, F108F, Q109Q, D158S, I159Y, L162H) and E11 (Y32H, L65Y, H70G, F108Y, Q109A, D158N, I159I, L162R), that conferred Cm resistance (>150 μg/mL) only in the presence of 1 ( Figure S1 and Table S1 of Supporting Information). Given the mutations and the structure, 18 we tried to understand the basis for recognition of 1 by the aaRSs (Figure S2 of SI). We had predicted that the negative charge on the phenolate of 1 would be the basis for discrimination against Y, and anticipated the introduction of positively charged side chains in the mutants. E3 contains a L162H mutation, but the protonation state of this residue is unknown. E11 contains a single basic side chain (L162R); however, a crystal structure of the p-acetylphenylalanine RS containing the same mutation revealed that the R side chain was directed away from the active site. 19 Y32 and/or D158 are mutated in both 2,3,5-F 3 Y-RSs to residues that could conceivably behave as Hbond donors to the phenolate of 1. The substitution of Gly at either position 65 (E3) or 70 (E11) may enlarge the substrate binding pocket. Thus, there exists minimal evidence indicating that the observed discrimination occurs on the basis of the phenolate. Instead, it appears that the fluorine substitutents provide the key recognition elements. The introduction and retention of many polar side chains provide opportunities for the three F atoms to participate in multipolar interactions of the nature C-F … H-N/O or C-F … C=O. 20 Given the sensitivity of these interactions to distance and geometry, it is impossible to speculate on the specific atoms involved without a high resolution structure. Crystallization attempts are underway to better under-stand the basis of F-protein interactions in the 2,3,5-F 3 Y-RSs. The nature of these interactions is of general interest, given the large number of fluorinated pharmaceuticals. 20 The aaRS hits were cloned into the previously described pEVOL system 21 for enhanced expression of proteins containing 1. We confirmed the selective incorporation of 1 into proteins by aaRSs E3 and E11 using pET-GFP Y151TAG , a plasmid that encodes a Cterminally His 6 tagged GFP. 15 Full-length, fluorescent protein is observed only when the TAG codon is suppressed by an amino-acylated tRNA. E3 afforded 10 mg/L of purified GFP, while E11 yielded 4 mg/L. Both aaRSs incorporated 1 into GFP with an observed mass of 27759 Da (expected: 27758 Da, Figure S3 of SI). In the absence of 1, low levels of phenylalanine incorporation could be detected for E3; however, this background incorporation is not detected in the presence of 1 (a property observed with several previously evolved aaRSs). 22a No background incorporation was detected for E11 in the absence of 1.
Recent experiments have shown that some aaRSs exhibit a degree of polyspecificity. 22 This feature arises from the lack of other UAAs in the selection medium to eliminate synthetases that can recognize them. To determine if these 2,3,5-F 3 Y aaRSs are polyspecific, they were screened against a diverse library of UAAs using a GFP fluorescence assay. 22a Of the ~80 UAAs in the library, both aaRSs were capable of aminoacylating 3-fluorotyrosine (2) and 3-chlorotyrosine (8) (Figure S4 of SI). The results of this first screen indicated the aaRSs exhibit some polyspecificity for other halogenated Ys, prompting a second GFP screen on Ys with a narrower range of substitutions (including 3-7, 9, 10). The evolved aaRSs were capable of incorporating all members of the F n Y series (3-FY (2), 2,3-F 2 Y (3), 3,5-F 2 Y (4), 2,3,6-F 3 Y (5), and 2,3,5,6-F 4 Y (6)), as well as several other halogenated analogs (Figure 1) . The incorporation of each UAA was confirmed by LC/MS analysis of the mutant GFPs ( Figure S5 of SI) . Interestingly, several of the analogs (2-5) were incorporated into GFP at higher levels than 1, thus our evolved aaRSs are henceforth called "F n Y-RSs." LC/MS analysis of E. coli lysate indicated that the reduced cellular uptake is one reason for the low incorporation of 6 relative to the other F n Ys.
The F n Y-RS E3 was then used to incorporate F n Ys into positions 730 and 731 of the RNR α2 subunit (Scheme 1). These residues have recently been shown to be sites of transient Y• formation during radical propagation by substitution of 3-aminotyrosine (NH 2 Y) 8 and 3-nitrotyrosine (NO 2 Y) 9 at these positions using similar technology. Cells were transformed with pEVOL-F n Y-RS-E3 and pET-nrdA Y730TAG , encoding for α with an N-His 6 tag and a stop codon at the position of Y 730 , 23 and grown in the presence of 1. SDS PAGE analysis of whole cells after induction revealed a ~1:1 ratio of full-length and truncated proteins ( Figure S6 
mg of protein/g cell paste (~50 mg/L culture). An analogous protocol was used to incorporate 3, 4 and 5 into position 730 of α2. The Y 730 F n Y-α2s were purified in yields of 2.5-3 mg/g (Table S2 of SI). Consistent with the GFP data (Figure 1 ), the yield of protein containing 6 was reduced 10-fold relative to other F n Ys. The 730-optimized protocol was then used to incorporate 1 and 4 into position 731 of α2 with comparable isolated protein yields. Finally, the expression protocol was used with minor modification to incorporate 1 at position 356 of β2 and the protein purified (2 mg/g).
Incorporation of F n Ys into position 122 of β2, the site of the stable Y• (t 1/2 ~ 4 days, 4 °C) in the wt, was of mechanistic interest. The reduction of Y 122 • occurs concomitant with oxidation of C 439 in α2 (Scheme 1), yet the intermediates of radical propagation in the wt enzyme are kinetically masked by rate-limiting conformational changes. 17 Thus, changes to Y 122 • or any of the pathway residues are undetectable by rapid biophysical techniques. Furthermore, even in those mutant RNRs in which radicals can be trapped and/or conformational gating can be partially lifted, observation and identification of new radicals by X-band EPR is complicated by their extensive spectral overlap. Recently, site-specific insertion of NO 2 Y at position 122 of β2 was described. Reaction of apo-Y 122 NO 2 Y-β2 with Fe 2+ and O 2 afforded assembly of a diferric-NO 2 Y 122 • cluster. 24 Use of the potent oxidant NO 2 Y 122 • as a radical initiator decoupled ET from the rate-limiting conformational change and allowed the first detection of a transient Y• on the pathway. 24, 25 However, the high redox potential of NO 2 Y relative to Y (Δ ~200 mV, pH 7) introduced complications to the system, namely the short half-life of NO 2 Y 122 • (t 1/2 ~ 40 s, 25 °C) and the mutant's inability to perform multiple turnovers.
Given these results, we sought to modulate the properties of position 122 more subtly using F n Ys. Given the known perturbation of the phenolic pK a at this position (>2.5 units), 9 UAAs 1 and 4 should be protonated at physiological pH and are predicted to be <10 mV harder and 50 mV easier to oxidize than Y•, respectively. Using pEVOL-F n Y-RS-E3 and pBADnrdB Y122TAG , encoding untagged β2 with a stop codon at position 122, 24 (Figure 2 , blue and cyan) are quite distinct from the EPR spectra of F n Y•s generated on the corresponding free amino acids by UV-photolysis. 4 The spectra of the latter are relatively featureless, with line broadening arising from a large distribution of dihedral angles for the β-methylene protons. In contrast, structural constraints imposed by the protein give rise to F n Y 122 • spectra with well-defined couplings to the fluorine nuclei (150-180 MHz) and one of the β-methylene protons (36-48 MHz). Spectral simulations (Figure 2 , red, and Table S3 ) were conducted using the parameters for 3-FY 122 • as an initial reference. 4 High-field EPR/ENDOR analysis of the F n Y•s is ongoing (Myers, Minnihan, Stubbe, and Britt).
Nucleotide reductase assays of Y 122 (2,3,5)F 3 Y-β2 revealed the mutant has 30% the wt β2 activity (scaled for radical). This result suggests that introduction of 2,3,5-F 3 Y at position 122 slightly perturbs radical propagation energetics and/or the conformational changes that gate it, but not to the extent that it prevents multiple catalytic turnovers. The reactivity of this mutant was further investigated by EPR spectroscopy. Y 122 (2,3,5)F 3 Y-β2 was mixed on ice with wt-α2, CDP (substrate) and ATP (allosteric effector) under single-turnover conditions in an EPR tube and quenched in a dry ice/acetone bath at 20 sec. The spectrum of the reaction mixture (Figure 3, black) • is used as a radical initiator (Figure 3, inset) . 24 Extensive evidence suggests that the new radical in the NO 2 Y mutant is primarily located at Y 356 . 25 While it is necessary to determine the kinetic competence of the new radical, observation of a putative Y 356 • is promising in two regards. First, the ability to observe an on-pathway Y• (while maintaining significant catalytic activity) will have important mechanistic implications. Investigations are under-way to determine what properties of F 3 Y allow observation of this new radical. We anticipate deriving additional insight into the long-range PCET mechanism by modulating the driving force and phenolic pK a at positions on the pathway in a step-wise fashion. Similarly, F n Ys may be utilized for mechanistic studies of ET and/or PT in model proteins and native enzymes. 8, 24 Thus, F n Y•s afford the first opportunity to identify low concentrations of radical species that would otherwise go undetected in complicated reaction mixtures. 25 F n Y•s may prove similarly useful in high-field EPR and ENDOR studies. For proteins that do not use radicals, F n Ys may be incorporated as probes of structure and/or local environment for 19 F-NMR studies. 28 Thus, application of F n Ys as spectroscopic probes may be extended to a broad biophysical research community.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material. Working mechanism for long-range PCET pathway in E. coli class Ia RNR The current hypothesis holds that protons (blue arrows) move orthogonally to the electron (red arrow) in β2 and co-linearly with the electron in α2. The mechanism across the α/β interface is unknown. There is no direct evidence that W 48 and its putative H + acceptor, D 237 , participate in long-range PCET during turnover.
